Physician profile
Marc Edward Walker
NPI 1245598325
$229,247.98
in general payments reported to CMS, 2019-2025
26 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.99 · 2020: $15.07 · 2021: $660 · 2022: $12K · 2023: $47K · 2024: $87K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $124K · Consulting Fee: $53K · Travel and Lodging: $31K · Food and Beverage: $7,918 · Grant: $1,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123,515.00 |
| Consulting Fee | $52,885.00 |
| Travel and Lodging | $30,808.24 |
| Food and Beverage | $7,917.94 |
| Grant | $1,410.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $116,161.03 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $52,300.96 | 2021-2024 | Xiaflex |
| Somavac Medical Solutions, INC. | $21,304.42 | 2021-2025 | Somavac 100 Sustained Vacuum System |
| Sonex Health, INC. | $16,840.48 | 2022-2025 | Sx-One Microknife |
| Axogen | $13,941.56 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Kerecis Limited | $5,582.08 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $348.99 | 2022-2023 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Acumed LLC | $342.71 | 2023-2025 | Acumed, Acumed, Innate Implant |
| Access Pro Medical, LLC | $286.48 | 2022-2023 | Matriderm |
| Depuy Synthes Sales INC. | $263.94 | 2022-2024 | Na |
| Skeletal Dynamics INC | $252.81 | 2024-2025 | Geminus, Ijs, Align |
| Stryker Corporation | $194.04 | 2021 | |
| Bioventus LLC | $192.54 | 2025 | Stimrouter Implantable Kit |
| Biocircuit Technologies INC | $182.25 | 2025 | Nerve Tape |
| Polynovo North America LLC | $146.08 | 2024 | Novosorb Btm |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $136.93 | 2022 | |
| Sientra, INC. | $130.00 | 2022 | |
| Baxter Healthcare | $115.46 | 2022 | |
| Davol INC. | $100.72 | 2024 | Phasix Mesh |
| Mentor Worldwide LLC | $84.75 | 2022 | |
| Kls-Martin L.P. | $80.76 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $68.25 | 2024 | |
| Smith+Nephew, INC. | $37.94 | 2021 | |
| Sanara Medtech INC. | $31.38 | 2022 | |
| Medline Industries Lp | $21.36 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,880.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.